Invasive Lobular Breast Carcinoma
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
Finally, we show that Wnt11 promotes activation of RhoA, which causes ILC anoikis resistance.
|
25713299 |
2015 |
ovarian neoplasm
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
The aims of the present study were three fold: i) to assess Wnt11 immunoexpression and its possible relationship with Wnt5a in high- and low-grade human serous ovarian cancer (HGSC and LGSC) specimens; ii) to assess Wnt11 expression levels in Wnt5a overexpressing SKOV-3 cells; iii) to reveal the role of Wnt11 in viability, adhesion, migration and invasion of SKOV-3 cells using recombinant human Wnt11 (rhWnt11).
|
24606488 |
2014 |
Malignant neoplasm of ovary
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
The aims of the present study were three fold: i) to assess Wnt11 immunoexpression and its possible relationship with Wnt5a in high- and low-grade human serous ovarian cancer (HGSC and LGSC) specimens; ii) to assess Wnt11 expression levels in Wnt5a overexpressing SKOV-3 cells; iii) to reveal the role of Wnt11 in viability, adhesion, migration and invasion of SKOV-3 cells using recombinant human Wnt11 (rhWnt11).
|
24606488 |
2014 |
Carcinoma, Ovarian Epithelial
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
The aims of the present study were three fold: i) to assess Wnt11 immunoexpression and its possible relationship with Wnt5a in high- and low-grade human serous ovarian cancer (HGSC and LGSC) specimens; ii) to assess Wnt11 expression levels in Wnt5a overexpressing SKOV-3 cells; iii) to reveal the role of Wnt11 in viability, adhesion, migration and invasion of SKOV-3 cells using recombinant human Wnt11 (rhWnt11).
|
24606488 |
2014 |
Malignant tumor of colon
|
0.010 |
Biomarker
|
disease |
BEFREE |
We also examined the functional effects of Wnt11 with the use of Wnt11 transfectants of colon cancer HCT-116 cells.
|
22161723 |
2013 |
Colon Carcinoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
We also examined the functional effects of Wnt11 with the use of Wnt11 transfectants of colon cancer HCT-116 cells.
|
22161723 |
2013 |
Ureteral obstruction
|
0.010 |
AlteredExpression
|
phenotype |
BEFREE |
Consistent with the in vitro results, all the TGF-β, Wnt11, and JNK targets were activated in a unilateral ureteral obstruction (UUO) model of renal fibrosis in vivo.
|
22556418 |
2012 |
Bacterial Infections
|
0.010 |
Biomarker
|
group |
BEFREE |
Wnt11 protein secretion in epithelial cells was also elevated after bacterial infection.
|
21903761 |
2011 |
Leukemia, Myelocytic, Acute
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
A larger sampling of patient diagnostic material revealed that ERG and WNT11 mRNA were co-expressed in 80% of AML (n=30) and 40% in T-ALL (n=30) bone marrow samples.
|
21242973 |
2011 |
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
A larger sampling of patient diagnostic material revealed that ERG and WNT11 mRNA were co-expressed in 80% of AML (n=30) and 40% in T-ALL (n=30) bone marrow samples.
|
21242973 |
2011 |
Prostatic Neoplasms
|
0.010 |
AlteredExpression
|
group |
BEFREE |
Wnt-11 protein levels in prostate tumours were determined by immunohistochemical analysis of prostate tumour tissue arrays.
|
20219091 |
2010 |
Secondary malignant neoplasm of bone
|
0.010 |
Biomarker
|
disease |
BEFREE |
Wnt-11 protein was elevated in 77/117 of tumours when compared with 27 benign prostatic hypertrophy specimens and was present in 4/4 bone metastases.
|
20219091 |
2010 |
Tumor Progression
|
0.010 |
AlteredExpression
|
phenotype |
BEFREE |
These observations suggest that the increased level of Wnt-11 found in prostate cancer contributes to tumour progression by promoting NED, tumour cell survival and cell migration/invasion, and may provide an opportunity for novel therapy in prostate cancer.
|
20219091 |
2010 |
Hepatocarcinogenesis
|
0.010 |
Biomarker
|
disease |
BEFREE |
These observations suggest a novel role for Wnt11 as a tumor suppressor during hepatocarcinogenesis because loss of expression promotes the malignant phenotype via both canonical and noncanonical Wnt signaling pathways.
|
20103596 |
2010 |
Liver carcinoma
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
The expression levels of Wnt11 mRNA and protein were significantly downregulated in human HCC tumors compared with the adjacent uninvolved liver as measured by quantitative real-time reverse transcription-PCR and Western blot analysis.
|
20103596 |
2010 |
Ulcerative Colitis
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
WNT2B, WNT3A, WNT5B, WNT6, WNT7A, WNT9A, and WNT11 exhibited significantly increased expression in UC compared to non-IBD patients.
|
17939044 |
2008 |
Papillary craniopharyngioma
|
0.010 |
Biomarker
|
disease |
BEFREE |
Human WNT5A, WNT5B, and WNT11 are representative non-canonical WNTs transducing PCP signals through FZD3 or FZD6 receptors, and ROR1, ROR2 or PTK7 co-receptors.
|
16273260 |
2005 |
Pneumocystis jiroveci pneumonia
|
0.010 |
Biomarker
|
disease |
BEFREE |
Human WNT5A, WNT5B, and WNT11 are representative non-canonical WNTs transducing PCP signals through FZD3 or FZD6 receptors, and ROR1, ROR2 or PTK7 co-receptors.
|
16273260 |
2005 |
Adenomatous Polyposis Coli
|
0.010 |
Biomarker
|
disease |
BEFREE |
Whereas ET lines demonstrated increased expression of microtubule-associated protein tau (MAPT), protein phosphatase 1 regulatory subunit 1A (PPP1R1A), NIMA (never in mitosis gene a)-related kinase 2 (NEK2), and cyclin D1 (CCND1), neuroblastoma samples exhibited high expression of wingless-type mouse mammary tumor virus integration site family member 11 (WNT11), Drosophila frizzled homolog 2 (FZD2), and adenomatous polyposis coli (APC) which are involved in regulating free beta-catenin levels.
|
11836553 |
2002 |
Renal Cell Carcinoma
|
0.010 |
AlteredExpression
|
disease |
LHGDN |
Among various types of human primary tumors, WNT11 mRNA was up-regulated in four cases of colorectal adenocarcinoma, and a case of renal cell carcinoma.
|
11712081 |
2001 |
Renal Cell Carcinoma
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
Among various types of human primary tumors, WNT11 mRNA was up-regulated in four cases of colorectal adenocarcinoma, and a case of renal cell carcinoma.
|
11712081 |
2001 |
Conventional (Clear Cell) Renal Cell Carcinoma
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
Among various types of human primary tumors, WNT11 mRNA was up-regulated in four cases of colorectal adenocarcinoma, and a case of renal cell carcinoma.
|
11712081 |
2001 |
Adenocarcinoma
|
0.020 |
AlteredExpression
|
group |
BEFREE |
The expression of Wnt11 and some NE markers increased after the transfection of ASCL1 into the A549 ADC cell line.
|
31231131 |
2019 |
Malignant neoplasm of breast
|
0.020 |
GeneticVariation
|
disease |
BEFREE |
This case-control study evaluated the association of SNPs in IRF6 (rs642961), WNT3A (rs708111), GSK3β (rs9879992), 8q24 (rs987525) and WNT11 (rs1533767), representing regions consistently identified as of susceptibility for oral clefts, with oral cancer (oral squamous cell carcinoma) and breast cancer.
|
30579133 |
2019 |
Squamous cell carcinoma
|
0.020 |
GeneticVariation
|
disease |
BEFREE |
This case-control study evaluated the association of SNPs in IRF6 (rs642961), WNT3A (rs708111), GSK3β (rs9879992), 8q24 (rs987525) and WNT11 (rs1533767), representing regions consistently identified as of susceptibility for oral clefts, with oral cancer (oral squamous cell carcinoma) and breast cancer.
|
30579133 |
2019 |